May 28, 2025By Tamra SamiEBR Systems raises $36M to sell Wise CRT therapyEBR Systems Inc. raised AU$55.9 million (US$36 million) to commercialize its Wise cardiac resynchronization therapy system following U.S. FDA approval in April of the wireless, endocardial pacing system to stimulate the heart’s left ventricle.